Humulin R
Dysglycemia
Nemours Children's ClinicN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Dysglycemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Exenatide Azienda Ospedaliero-Universitaria di Parma | Phase 3 | B |
Cystadane Joslin Diabetes Center | Phase 2 | B |
LAC VACCINUM University of Toronto | N/A | D |
ALLULOSE University of Toronto | D | |
GLUCOSE, ANHYDROUS Nemours Children's Clinic | N/A | D |
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →